Literature DB >> 6220409

Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors.

I Löwy, C Brezin, C Neauport-Sautes, J Theze, W H Fridman.   

Abstract

T2D4, a T-cell hybrid, spontaneously secretes suppressive immunoglobulin factor(s); when incubated with purified monoclonal mouse immunoglobulins, this hybrid produces high levels of immunoglobulin-binding factors specific for the subclass of the inducing immunoglobulin. Thus, we were able to induce the production of IgG1- or IgG2-specific inhibitory factors by the same T2D4 T-cell hybrid. These subclass-specific suppressive factors bind selectively to the IgG1 or IgG2 subclasses and inhibit specifically the secretion of antibodies of the corresponding subclass. Our results favor a model of negative regulation of isotype expression in which a given isotype triggers suppressor mechanism(s) specifically inhibiting its production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220409      PMCID: PMC393812          DOI: 10.1073/pnas.80.8.2323

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors.

Authors:  J Yodoi; K Ishizaka
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

Review 2.  Regulation of IgE in mice.

Authors:  Z Ovary; T Itaya; N Watanabe; S Kojima
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

3.  Regulatory circuits and antibody responses.

Authors:  L A Herzenberg; S J Black; L A Herzenberg
Journal:  Eur J Immunol       Date:  1980-01       Impact factor: 5.532

4.  T-cell hybrids bear Fcgamma receptors and secrete suppressor immunoglobulin binding factor.

Authors:  C Neauport-Sautes; C Rabourdin-Combe; W H Fridman
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

5.  Characterization of suppressor cells regulating in vitro expression of IgG2A and IgG2B antibody responses.

Authors:  I Löwy; M Joskowicz; J Theze
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

6.  Formation of IgE-binding factors by rat T lymphocytes. III. Mechanisms of selective formation of IgE-suppressive factors by treatment with complete Freund's adjuvant.

Authors:  M Hirashima; J Yodoi; T F Huff; K Ishizaka
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Heavy chain-specific suppression of immunoglobulin synthesis and secretion by lymphocytes from patients with selective IgA deficiency.

Authors:  S A Schwartz
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

8.  Functional analysis of GAT-specific T cell clones: H-2-restricted monoclonal T helper cells do not regulate expression of antibody isotypes.

Authors:  M Seman; V Zilberfarb; M L Gougeon; J Theze
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

9.  T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch.

Authors:  P K Mongini; W E Paul; E S Metcalf
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  Suppression of in vitro antibody synthesis by immunoglobulin-binding factor.

Authors:  R H Gisler; W H Fridman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  17 in total

1.  In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.

Authors:  C Mathiot; S Amigorena; J Moncuit; C Sautès; W H Fridman; J L Teillaud
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Potentiating and suppressive IgE-binding factors are expressed by a single cloned gene.

Authors:  C L Martens; P Jardieu; M L Trounstine; S G Stuart; K Ishizaka; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones.

Authors:  M L Hibbs; I D Walker; L Kirszbaum; G A Pietersz; N J Deacon; G W Chambers; I F McKenzie; P M Hogarth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  IgD-binding factors from mouse T lymphocytes.

Authors:  M Adachi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls.

Authors:  M G Scott; M H Nahm; K Macke; G S Nash; M J Bertovich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

6.  An IgM-producing immunocytoma induces large numbers of splenic T lymphocytes with Fc mu receptors.

Authors:  F Uher; E Puskás; J Gergely; H Bazin
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

7.  cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma.

Authors:  C L Martens; T F Huff; P Jardieu; M L Trounstine; R L Coffman; K Ishizaka; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD.

Authors:  A R Amin; R F Coico; F Finkelman; G W Siskind; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms.

Authors:  S S Chen; F T Liu; D H Katz
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.

Authors:  A Lynch; E Tartour; J L Teillaud; B Asselain; W H Fridman; C Sautès
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.